Is there a list of new features requested or bugs that need to be fixed. How would developers contribute if the were just getting involved on some volenteer part time basis?
Unconfigured Ad
Collapse
X
-
Hello Ashreid,
We would love to have more people contributing to the codebase.
Getting started, I would first make sure you can:- Clone the source from github and build openge (See the developer docs for compilation instructions)
- Run the tests (make test)
- Branch the source so you have something to develop against
We don't have a public list of features and bugs to work on, but here are a couple of things off the top of my head:- Add additional testing. Most of the built in tests simply execute openge with valid inputs, but don't check the output of tests. More robust testing would be useful to us. Check out run.sh from this test that I just checked in for an example: here
I have been meaning to verify that we have full test coverage for both SAM and BAM inputs, being passed in as a filename, as well as piped into OpenGE. A good test (or set of tests) would verify that we can run:
just as well asCode:cat asdf.bam | ./openge count
orCode:./openge asdf.bam
Complete test coverage of all input types would be helpful; IO code is where we find the most bugs currently.Code:./openge count < asdf.bam.
- The CMake build system supports building packages for linux platforms (see here). It would be great if we could build .deb and .rpm packages with a command that included the appropriate binary and referenced necessary dependencies.
- Additional features. If you're interested on working on additional features, we will need to coordinate with David (adaptivegenome). He's the guy in charge of deciding what goes into openge.
If you have patches to contribute, please branch the openge source on github and submit a pull request with your modifications and we'll have a look.
-Lee
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
43 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment